featured research Archives
Nov. 12, 2015—Vanderbilt investigators have generated a “parts list” for the molecular machinery that duplicates DNA each time a cell divides. The research has implications for cancer therapies that target components of this machinery.
Sep. 30, 2015—Children with autism who participated in a 10-week, 40-hour, theatre-based program showed significant differences in social ability compared to a group of children with autism who did not participate, according to a Vanderbilt study published in the Journal of Autism and Developmental Disorders.
Sep. 3, 2015—Vanderbilt University is seizing the opportunity to become a hub for music research in the heart of Music City.
Jun. 18, 2015—A new study led by Vanderbilt University Medical Center investigators found new diagnoses of prostate cancer in the U.S. declined 28 percent in the year following the draft recommendation from the United States Preventive Services Task Force against routine PSA screening for men.
May. 28, 2015—Unstable federal research funding and reductions in health care revenue for academic medical centers threatens to undermine the nation’s biomedical research enterprise, and in turn clinical medicine, which the nation needs now more than ever.
May. 21, 2015—The Vanderbilt-based Mid-South Clinical Data Research Network (CDRN) is among seven CDRNs that will collaboratively mount a three-year, $14 million randomized clinical trial to determine the best daily dose of aspirin for preventing heart attacks and strokes among people living with heart disease.
Vanderbilt study finds babies exposed to narcotic pain relievers more likely to experience drug withdrawal syndrome
Apr. 13, 2015—Legally prescribed narcotics taken during pregnancy can lead to neonatal abstinence syndrome, especially in combination with tobacco or SSRIs.
Feb. 26, 2015—Andrew Ekelem, who has used a wheelchair since a college snowboarding accident, brings an invaluable perspective to the lab of mechanical engineer Michael Goldfarb.
Feb. 5, 2015—Vanderbilt biologists have found a direct link between the biological clock and Angelman syndrome, a neurogenetic disorder that occurs in more than one in every 15,000 live births. The link may provide a valuable way to judge the effectiveness of the first experimental drugs under development for treating the syndrome.